| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |